| |
| Issue |
Title |
| |
| No 1 (2024) |
Interaction of CYP3A4, CYP3A5, CYP1A1 and CYP2B6 genes in the development of organotoxic effects of chemotherapy in patients with Hodgkin's lymphoma |
Abstract
PDF (Rus)
|
|
V. A. Vavilin, O. B. Goreva, Ya. Yu. Shebunyaeva, S. I. Makarova, M. S. Voitko, A. Yu. Grishanova, T. I. Pospelova |
| |
| No 1 (2024) |
Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review |
Abstract
PDF (Rus)
|
|
R. F. Nasyrova, A. V. Kidyaeva, V. V. Grechkina, N. A. Shnayder |
| |
| No 1 (2022) |
First phase of antipsychotic metabolism in the liver: the role of oxidation |
Abstract
PDF (Rus)
|
|
N. A. Shnayder, A. K. Khasanova, R. F. Nasyrova |
| |
| No 1 (2022) |
Pharmacogenetic predictors of the safety of nonsteroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
A. S. Zhiryakova, N. P. Denisenko, A. V. Kryukov, A. V. Matveev, K. B. Mirzaev, D. A. Sychev |
| |
| No 1 (2022) |
The role of DNA-profiling in predicting anticonvulsant-induced QT prolongation diseases based on pharmacogenetic aspects |
Abstract
PDF (Rus)
|
|
N. M. Zhuravlev, N. A. Shnayder, R. F. Nasyrova |
| |
| No 1 (2021) |
Safety assessment of a new anti-tuberculosis drug in silico and with the participation of healthy volunteers |
Abstract
PDF (Rus)
|
|
A. Yu. Savchenko, G. V. Ramenskaya, V. G. Kukes, M. S. Burenkov, B. V. Shilov |
| |
| 1 - 6 of 6 Items |
|
